Document Detail


Management and therapy of human immunodeficiency virus-infected pregnancies in maternal-fetal medicine fellowship training programs.
MedLine Citation:
PMID:  1448269     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine attitudes and practices of obstetricians in maternal-fetal medicine fellowship programs regarding the management of human immunodeficiency virus (HIV) infection and the use of zidovudine during pregnancy. METHODS: We sent a questionnaire to the directors of all 78 approved maternal-fetal medicine fellowship programs. The responses, reflecting the consensus of the staffs of each program, were obtained and tabulated. RESULTS: Although their programs annually provide care for more than 2100 pregnant women infected with HIV, less than 25% of all maternal-fetal medicine fellowship directors reported that their patients participate in multicenter studies of HIV infection complicating pregnancy. Nearly two-thirds of the infected women are excluded from such multicenter studies. More than 70% of all program directors believe that zidovudine should be offered to symptomatic pregnant women infected with HIV; one-half question whether zidovudine poses short-term fetal risks. Nevertheless, nearly half of all HIV-infected pregnant women they manage are excluded from trials of zidovudine therapy during pregnancy. CONCLUSIONS: Many HIV-infected pregnant women who receive care in clinics of maternal-fetal medicine fellowship programs are excluded from multicenter studies. Consideration should be given to creating a national registry for this important, currently unreported, clinical resource.
Authors:
J H Grossman; B M Nies; J Lopez-Zeno; S L Bathgate; D M Parenti
Related Documents :
10585809 - Hantavirus pulmonary syndrome in pregnancy.
22264579 - Management of familial hypercholesterolemia during pregnancy: case series and discussion.
20818959 - Pregnancy-associated parvovirus b19 infection causing postinfectious glomerulonephritis.
17566949 - Idiopathic vertebral abscess in pregnancy: case report and literature review.
24455349 - Importance of close follow-up in the fetus with premature atrial contractions accompani...
22621699 - Correction: pessaries in multiple pregnancy as a prevention of preterm birth: the protw...
11336729 - Spectral analysis of fetal heart rate variability as a predictor of intrapartum fetal d...
11594539 - Contractility of the nonpregnant uterus: the follicular phase.
636859 - Delivery complicated by myasthenia gravis and epilepsy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  80     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  1992 Dec 
Date Detail:
Created Date:  1992-12-24     Completed Date:  1992-12-24     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  985-8     Citation Subset:  AIM; IM; X    
Affiliation:
Division of Maternal-Fetal Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic / utilization
Fellowships and Scholarships*
Female
HIV Infections / drug therapy*
Health Knowledge, Attitudes, Practice*
Humans
Obstetrics* / education
Perinatology / education
Pregnancy
Pregnancy Complications, Infectious / drug therapy*
Specialty Boards
United States
Zidovudine / therapeutic use*
Chemical
Reg. No./Substance:
30516-87-1/Zidovudine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Crack cocaine: a risk factor for human immunodeficiency virus infection type 1 among inner-city part...
Next Document:  The epidemiology of pregnancy complications and outcome in a Norwegian twin population.